Evidence map›Paper›PMID 39003428›Full record

ArticleJournal of neurology2024

Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis.

Veronica Ravano, Michaela Andelova, Gian Franco Piredda, Stefan Sommer, Samuele Caneschi, Lucia Roccaro, Jan Krasensky, Matej Kudrna, Tomas Uher, Ricardo A Corredor-Jerez and 8 more

Abstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Veronica RavanoAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland. veronica.ravano@siemens-healthineers.com.ORCID http://orcid.org/0000-0002-1532-9664
Michaela AndelovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-3812-7483
Gian Franco PireddaAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8449-6634
Stefan SommerAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3484-1679
Samuele CaneschiAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.
Lucia RoccaroAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.
Jan KrasenskyDepartment of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-5605-8821
Matej KudrnaDepartment of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Tomas UherDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-3160-9022
Ricardo A Corredor-JerezAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8172-9850
Jonathan A DisselhorstAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2924-1866
Bénédicte MaréchalAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7866-2854
Tom HilbertAdvanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0001-8207-4908
Jean-Philippe ThiranLTS5, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-2938-9657
Jonas RichiardiDepartment of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-6975-5634
Dana HorakovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-1915-0036
Manuela Vaneckova *Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.ORCID http://orcid.org/0000-0001-6895-3738
Tobias Kober *Advanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Geneva and Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7598-9456

Funding

Charles University Hospital Prague RVO VFN 64165Czech Ministry of Education Project cooperation LF1Czech Ministry of Health NU 22-04-001Roche NTC03706118
6 · The paper itself

Abstract

BACKGROUND AND

objectivesIn multiple sclerosis (MS), slowly expanding lesions were shown to be associated with worse disability and prognosis. Their timely detection from cross-sectional data at early disease stages could be clinically relevant to inform treatment planning. Here, we propose to use multiparametric, quantitative MRI to allow a better cross-sectional characterization of lesions with different longitudinal phenotypes.

methodsWe analysed T1 and T2 relaxometry maps from a longitudinal cohort of MS patients. Lesions were classified as enlarging, shrinking, new or stable based on their longitudinal volumetric change using a newly developed automated technique. Voxelwise deviations were computed as z-scores by comparing individual patient data to T1, T2 and T2/T1 normative values from healthy subjects. We studied the distribution of microstructural properties inside lesions and within perilesional tissue. RESULTS AND

conclusionsStable lesions exhibited the highest T1 and T2 z-scores in lesion tissue, while the lowest values were observed for new lesions. Shrinking lesions presented the highest T1 z-scores in the first perilesional ring while enlarging lesions showed the highest T2 z-scores in the same region. Finally, a classification model was trained to predict the longitudinal lesion type based on microstructural metrics and feature importance was assessed. Z-scores estimated in lesion and perilesional tissue from T1, T2 and T2/T1 quantitative maps carry discriminative and complementary information to classify longitudinal lesion phenotypes, hence suggesting that multiparametric MRI approaches are essential for a better understanding of the pathophysiological mechanisms underlying disease activity in MS lesions.

Indexed as

Multiple SclerosisPhenotypeAdultBrainCross-Sectional StudiesDisease ProgressionFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedMultiparametric Magnetic Resonance ImagingEnlarging lesionsLesion subtypingMultiple sclerosisQuantitative MRIRelaxometry

Identifiers

PMID39003428
PMCPMC11377637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.